Enzymatic “Click” Ligation: Selective Cysteine Modification in Polypeptides Enabled by Promiscuous Glutathione S-Transferase by Zhang, Chi et al.
Enzymatic “Click” Ligation: Selective Cysteine Modification in
Polypeptides Enabled by Promiscuous Glutathione S-
Transferase**
Chi Zhang, Alexander M. Spokoyny, Yekui Zou, Mark D. Simon, and Bradley L. Pentelute*
Department of Chemistry Massachusetts Institute of Technology 77 Massachusetts Avenue, MA
02139, USA
Keywords
Bioconjugation; Click Chemistry; Cysteine Arylation; Enzyme Promiscuity; Peptide
Macrocyclization
Post-translational modifications of biomolecules represent nature's versatile chemical
toolbox, allowing for precise and on-demand placement of various functional moieties in
vivo.[1] Synthetic chemists have strived to develop a similar reaction toolkit with chemical
orthogonality, selectivity and reactivity comparable to those of natural systems.[2] Recently,
“click” chemistry has produced several powerful transformations applicable to a wide range
of synthetic settings.[3] While the efficiency and chemical orthogonality of such “click”
processes are remarkable, regio-control for these transformations has been limited and
remains a major challenge.[4] The difficulty of selectively differentiating between two
chemically identical sites within a macromolecule is routinely surmounted in natural
systems by recognition elements such as binding pockets, directing groups and allosteric
components. Although various enzymes have been engineered to catalyze reactions for
protein modification and engineering,[5] they often require a long recognition sequence in
polypeptides, and their substrate scope is relatively restricted. In certain cases enzymes are
capable of recognizing and carrying out efficient transformations on more than one specific
substrate, a phenomenon known as enzyme promiscuity. Promiscuous enzymes have been
previously engineered to catalyze several synthetically important organic transformations.[6]
Synthetic methods for modifying biomolecules provide opportunities for studying protein
structure-function relationships as well as creating proteins with new properties and
applications.[7] Cysteine (Cys) is often chosen for modification because of the unique
reactivity of its thiol group [8] as well as the low abundance of Cys residues in the majority
of naturally occurring proteins (ca. 1.7%).[9] Various chemical methods for Cys
modification have been developed, such as alkylation[10], oxidation[11], and
desulfurization[12]. Recently, we developed a perfluoroaryl-cysteine SNAr chemistry
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approach to modifying unprotected peptides (Figure 1A).[13] While this method satisfies
several requirements of “click” chemistry,[14] the insolubility and low reactivity of the
perfluoroaromatic reagents in aqueous media restricts the general application of this process
to a narrow range of biomolecules. In our search to render this chemistry suitable for
aqueous conditions we turned our attention to glutathione S-transferase (GST).[15] Known as
a class of promiscuous enzymes, GST catalyzes conjugation reactions between the Cys
residue of glutathione (GSH, γ-Glu-Cys-Gly) and various electrophiles, thus allowing the
cell to detoxify xenobiotics in vivo (Figure 1B).[15a]
Here we report a novel bioconjugation chemistry that combines a previously developed
perfluoroaryl-cysteine SNAr “click” reaction with GST enzyme catalysis (Figure 1C). The
promiscuous nature of GST facilitates the bioconjugation with polypeptides other than GSH
in aqueous media and provides previously unattainable chemo- and regioselective
functionalization of a single cysteine thiol in the presence of other unprotected cysteine
residues and reactive functional groups on the same polypeptide chain. Furthermore, we
show that this process can be completed in seconds, thereby providing a new and efficient
approach to peptide macrocyclization. This chemistry can be carried out over a broad range
of temperatures (4-60°C) and is compatible with the addition of organic co-solvents (up to
20%).
We hypothesized that the broad scope of electrophiles accepted by GST isozymes might be
sufficient for members of this enzyme family to mediate reactions between perfluoroaryl
electrophiles and peptides containing GSH in an aqueous environment. To achieve the
broadest electrophile scope, a mixture of GST isozymes was chosen for screening.[16] We
first tested the GST-catalyzed conjugation of GSH to model peptides containing L-
pentafluorophenylalanine (residue I, Figure 2A). Reacting 1 with GSH at 37 °C in aqueous
solution at pH 8.0 with 2 mg/mL GST (ca. 5-10 mol% relative to 1) for two hours generated
conjugated product 2, as confirmed by LCMS analysis (Figure S6), whereas no product was
observed without the enzyme. Nucleophilic residues in model peptide 1, such as Cys and
Lys, were unreactive, indicating that the Cys of GSH can be selectively modified with
pentafluorophenyl-based electrophiles under GST catalysis.
To examine the substrate scope of this reaction, we first tested whether the mixture of GST
isozymes could catalyze the conjugation of L-pentafluorophenylalanine residue to peptides
bearing N-terminal GSH (γ-Glu-Cys-Gly). However, a hexapeptide containing N-terminal
glutathione sequence (γ-Glu-Cys-Gly-Gly-Leu-Leu) did not show reactivity towards 1
(Figure S7). We then hypothesized that increasing the electrophilicity of the perfluoroaryl
moiety might improve the reactivity of the peptide-based substrate sufficiently to allow
GST-mediated conjugation with peptides containing N-terminal GSH sequence. Our
previous study showed that para-thioether substituent on the perfluoroaryl moiety can
stabilize the negative charge of the SNAr reaction intermediate thereby increasing the
reaction rate.[13] We evaluated the enzymatic reactivity of peptides containing several para-
thioether substituted electrophiles derived from cysteine. Importantly, reactions with these
peptides showed enhanced reaction rates as compared to peptide containing L-
pentafluorophenylalanine (residue I, Figure 2A and Figure S7). Specifically, peptide
containing cysteine modified with perfluorophenyl residue (Cys-II) (Figure 2A and 2C, 3a;
Figure S1 for synthesis) reacted with GSH in the presence of GST at a significantly higher
rate as compared to 1, yielding 93% of GSH-conjugated product in less than four hours.
Reactions with peptides containing Cys moiety functionalized with perfluorobiphenyl
species (Cys-III) (Figure 2A and 2B, 3b) and perfluorobiphenyl sulfide (Cys-IV) (Figure
2A, 3c) proceeded with quantitative conversions in less than 30 minutes (Figure 2C).
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Using more reactive electrophiles, we conducted studies beyond the GSH substrate. We
focused on ligations between peptides containing Cys-III residue and hexamer peptides with
an N-terminal γ-Glu-Cys-Gly. Our study commenced with the synthesis of glycyl-modified
GSH-based peptides, where the first amino acid directly after GSH was varied (Figure 3, 5a-
e). All reactions proceeded quantitatively within two hours (Figure 3, entries 1-5), and
reaction with 5a showed high conversion within 30 minutes (Figure 3, entry 1). Decreased
reaction rates with 5b and 5e as compared to 5a were observed, suggesting this site may be
important for interacting with GST. Changing the second amino acid in the sequence linked
to the Gly site to a less bulky residue (Figure S13F) had no effect on the conjugation rate.
Nucleophilic residues (His and Lys, Figure 3, entries 3 and 4) are compatible with the
reaction. Surprisingly, the reaction with 5c produced 98% conversion within 30 minutes,
suggesting that His residue may favor the reaction.
While the residue C-terminal to GSH can affect the relative rates of the GST-catalyzed
reaction, the observed product yield for reactions with Cys-III has thus far been independent
of the peptide sequence employed, further suggesting that the electrophilicity of the
perfluoroaryl substituents can dominate the GST-catalyzed SNAr reaction with modified
GSH (vide supra). These results show the promiscuity associated with GST is adequate to
catalyze the selective bioconjugation of two unprotected polypeptide fragments and is
unique, as it demonstrates the possibility of enhancing a click reaction via enzymatic
catalysis.[17]
This reaction is highly selective for arylation of Cys thiols, as evidenced by the competition
experiment with a large excess of exogenous thiol (4-mercaptophenylacetic acid - MPAA,
100-fold, Figure S8). No MPAA-arylated product was generated, while the GST-catalyzed
product was exclusively produced. In addition, reacting peptide 3b with another peptide 5k
containing C-terminal hydrazide moiety and N-terminal γ-Glu-Cys-Gly sequence gave
solely S-arylated product 6k, which could be further modified by hydrazone ligation (Figure
S8).[18]
The unique chemo- and regioselectivity of the GST-catalyzed arylation reaction could be
exploited to label one Cys residue in the presence of another on a fully unprotected peptide
or protein. We first labeled the N-terminal GSH Cys with biotin and subsequently modified
a separate Cys with a fluorophore maleimide. This provides the first example of orthogonal
site-specific labeling of two unprotected Cys residues within the same unprotected peptide
or protein. Biotin probe containing Cys-III moiety (Figure 4A, 11, see Figure S3 for
synthesis) was conjugated to the Cys position of N-terminal γ-Glu-Cys-Gly fragment in
protein 7 (see Figure S4 for synthesis). The enzymatic reaction produced the mono-labeled
product 8, and the other cysteine was labeled with fluorescein-5-maleimide 10, thereby
producing the site-specific dual-labeled protein species 9 (Figure 4A). Using similar
protocol, the biotin and fluorescein probes were regiospecifically attached to peptide 14 to
produce the dual labeled species 16 (Figure S10). The authentic sample was prepared using
conventional protecting-group chemistry to confirm the identity of mono-labeled peptide
species 15 (Figure S16). Importantly, regiospecific and orthogonal modification of two
chemically identical Cys sites was enabled by GST selective recognition of the N-terminal
GSH moiety. This result indicates that the GST-catalyzed arylation could greatly expand the
scope of previous cysteine modification methods, which necessitate the use of protecting
groups or multiple steps to differentially functionalize two or more cysteine residues.[19]
Cyclic peptides constitute a very important class of medicinally relevant macrocycles.[20]
Although various methods have been previously developed,[21] synthesis of macrocyclic
peptide fragments remains challenging. We found intramolecular arylation catalyzed by
GST of peptide 12 containing γ-Glu-Cys-Gly fragment and Cys-III site afforded
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quantitative conversion to the cyclized product 13 in less than 30 seconds (Figure 4B). In
contrast, the control experiment without GST showed no product formation as observed by
LCMS analysis. Furthermore, the cyclization reaction was shown to be dominant even with
GSH added as a competing substrate (Figure S11). The perfluorinated moiety used in this
example can potentially enhance the cell-permeability of cyclic peptides as shown
previously.[13]
This GST mediated transformation is not limited to specific temperatures, solvent conditions
and peptides featuring γ-Glu-Cys-Gly sequence. For example, the reaction between 3b and
GSH under GST catalysis produces the desired arylated product 4b at temperatures ranging
from 4 to 60 °C (Figure 4C, right panel), as well as in the presence of up to 20% organic co-
solvent (Figure 4C, left panel). Additionally, GSH analogues with the mutation of γ-Glu to a
genetically encodable Glu or Asp (Glu-Cys-Gly or Asp-Cys-Gly) undergo facile S-arylation
with peptide 3b under the developed GST-catalyzed conditions (Fig. S17). Finally, our
experiments show that N-terminal Glu-Cys-Gly or Asp-Cys-Gly sequences in peptides
(Figure S12, 5g and 5h) can also be selectively S-arylated with peptide 3b though with
lower efficiency as compared to peptides with N-terminal γ-Glu-Cys-Gly moiety (Figure
S13A, 5a). These results are consistent with previous findings that certain GST isozymes are
capable of catalyzing the SNAr reaction between 1,4-dinitrochlorobenzene and glutathione
analogues.[22] Together, our observation suggests that the requirement for an N-terminal γ-
glutamic acid residue could be eliminated with engineered GST.
In conclusion, we demonstrated a powerful glutathione S-transferase catalyzed SNAr “click”
process for site-specific cysteine modification. This method allowed us to selectively modify
cysteine in an N-terminal γ-Glu-Cys-Gly sequence within peptide and protein chains. The
unique chemical orthogonality of the discovered arylation enabled by GST provides a route
to modifying multiple cysteine sites with different chemical probes or biomolecules while
avoiding the use of protecting groups and additional synthetic procedures. By showing how
a naturally occurring enzyme catalyst improves and significantly broadens the scope of an
established “click” synthetic transformation, this discovery paves a frontier in discovering
new enzyme mediated reactivity modes suited for chemoselective modification of
biomolecules.
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A) Peptide “click” modification via perfluoroaryl-cysteine SNAr chemistry. B) GST-
catalyzed SNAr reaction. GST catalyzes the conjugation of activated aromatic electrophiles
to GSH cysteine thiol. EWG: electron withdrawing group, LG: leaving group. C) GST -
catalyzed cysteine arylation. GST catalyzes the conjugation of probes bearing 4-
mercaptoperfluoro-biphenyl moiety (Cys-III) to the N-terminal γ-Glu-Cys-Gly sequence of
a peptide or a protein. Amino acids are shown in single-letter code. γ-E stands for γ-
glutamyl.
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A) GST-catalyzed conjugation of GSH with peptides containing perfluoroaromatic
electrophilic residues. Peptide sequence of 1: NH2-ITPCNLLF*YYGKKK-CONH2, F*
stands for L-pentafluorophenylalanine; peptide sequences of 3a-c: H2NVTLPSTC*GAS-
CONH2, C* refers to the modified cysteine. Reaction conditions: 1 mM 1 or 3a-c, 1 mM
GSH, 2 mg/mL GST, 20 mM tris(2-carboxylethyl)phosphine hydrochloride (TCEP·HCl),
0.1 M phosphate buffer, pH 8.0, 37 °C. B) LCMS analysis of crude reaction with peptide
containing Cys-III residue after 30 minutes. C) Rates of formation of GSH-conjugated
product with different electrophiles (see Figure S14 for complete LCMS analysis). Yields
were determined by LCMS analysis (see SI).
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Conjugation of peptide 3b containing Cys-III residue (H2N-VTLPSTC*GAS-CONH2, C*
refers to the modified cysteine) to peptides with N-terminal γ-Glu-Cys-Gly sequence
featuring varied neighboring amino acid residues under GST-catalysis. Yields were
determined by LCMS analysis at λ=280 nm (see SI) after 30 minutes. Reaction conditions: 2
mM 3b, 1 mM 5a-e, 2 mg/mL GST, 20 mM TCEP·HCl, 0.1 M phosphate, pH 8.0, 37 °C. [*]
Yields for reactions at 120 minutes.
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Synthetic utility of GST-catalyzed cysteine modification. LCMS traces are shown as total
ion current. Yields were determined by LCMS analysis at λ=280 nm (see SI). A) Sequential
labeling of protein 7 containing two Cys residues with biotin and fluorescein probes. Crystal
structure shown is the N-terminal domain of anthrax toxin lethal factor 1-263, PDB ID:
1J7N. Reaction conditions: (1) 0.5 mM 11, 26 μM 7, 2 mg/mL GST, 20 mM TCEP·HCl, 0.1
M phosphate, pH 8.0, 37 °C, 2 hours; (2) 13 μM 8, 100 μM 10, 0.1 M phosphate, pH 6.0,
room temperature, 10 minutes. B) Peptide macrocyclization catalyzed by GST. Reaction
conditions: 1 mM 12, 2 mg/mL GST, 20 mM TCEP·HCl, 0.1 M phosphate, pH 8.0, 37 °C.
C) GST-catalyzed conjugation of GSH to peptide containing Cys-III residue with mixed
solvent at variable conditions and temperatures. Reaction conditions were the same as those
in Figure 1 except for solvents (Left panel, percentages shown as volume ratio) and
temperatures (right panel), see Figure S15 for complete LCMS analysis. DMF:
dimethylformamide, DMSO: dimethylsulfoxide, i-PrOH: isopropanol.
Zhang et al. Page 9
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2014 December 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
